Abstract
Obstructive sleep apnea syndrome (OSAS) is a common disorder characterized by recurrent episodes of upper airway obstruction resulting in oxygen desaturations and sleep disruption. OSAS is associated with an augmented risk for cardiovascular and cerebrovascular morbidity and mortality. Several mechanisms have been proposed to explain the association between OSAS and cardiovascular dysfunction. Low-grade systemic inflammation may contribute to the development of the cardiovascular and metabolic diseases associated with OSAS. The purpose of this review is to summarize current evidence on the association between OSAS and markers of systemic inflammation.
Keywords: Inflammation, inflammatory markers, obstructive sleep apnea syndrome.
Current Respiratory Medicine Reviews
Title:Markers of Systemic Inflammation in Obstructive Sleep Apnea Syndrome
Volume: 12 Issue: 2
Author(s): Kostas Archontogeorgis, Evangelia Nena, Maria Xanthoudaki and Demosthenes Bouros
Affiliation:
Keywords: Inflammation, inflammatory markers, obstructive sleep apnea syndrome.
Abstract: Obstructive sleep apnea syndrome (OSAS) is a common disorder characterized by recurrent episodes of upper airway obstruction resulting in oxygen desaturations and sleep disruption. OSAS is associated with an augmented risk for cardiovascular and cerebrovascular morbidity and mortality. Several mechanisms have been proposed to explain the association between OSAS and cardiovascular dysfunction. Low-grade systemic inflammation may contribute to the development of the cardiovascular and metabolic diseases associated with OSAS. The purpose of this review is to summarize current evidence on the association between OSAS and markers of systemic inflammation.
Export Options
About this article
Cite this article as:
Archontogeorgis Kostas, Nena Evangelia, Xanthoudaki Maria and Bouros Demosthenes, Markers of Systemic Inflammation in Obstructive Sleep Apnea Syndrome, Current Respiratory Medicine Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573398X10666141105234647
DOI https://dx.doi.org/10.2174/1573398X10666141105234647 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Central Nervous System Agents Used as Trypanosoma cruzi Infection Chemotherapy: Phenothiazines and Related Compounds
Current Medicinal Chemistry - Anti-Infective Agents ATP-Sensitive Potassium Channel Modulators and Cardiac Arrhythmias: An Update
Current Pharmaceutical Design Editorial: (Thematic Issue: Plant Polyphenols and Health Benefits)
Current Pharmaceutical Design Potential Treatment of Cardiac Hypertrophy and Heart Failure by Inhibiting the Sarcolemmal Binding of Phospholipase Cβ1b
Current Drug Targets Editorial [Hot Topic : Current Practice and trends in echocardiography in Critical Care, Anesthesiology and Emergency Medicine (Guest Editor: Paulo Marcelino)]
Current Cardiology Reviews The Role of Inflammation in Epicardial Adipose Tissue in Heart Diseases
Current Pharmaceutical Design Microarray Profiling Analysis Uncovers Common Molecular Mechanisms of Rubella Virus, Human Cytomegalovirus, and Herpes Simplex Virus Type 2 Infections in ECV304 Cells
Current Molecular Medicine Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Sympathetic and Baroreflex Function in Hypertension: Implications for Current and New Drugs
Current Pharmaceutical Design Low Levels of High Density Lipoprotein Increase the Severity of Cerebral White Matter Changes:Implications for Prevention and Treatment of Cerebrovascular Diseases
Current Alzheimer Research Current Status of Rho-Associated Kinases (ROCKs) in Coronary Atherosclerosis and Vasospasm
Cardiovascular & Hematological Agents in Medicinal Chemistry Implication for Thiazolidinediones (TZDs) as Novel Potential Anti- Inflammatory Drugs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Coal Mine Dust Lung Disease: The Silent Coal Mining Disaster
Current Respiratory Medicine Reviews Editorial (Thematic Issue: Medication Management for People with Dementia or Cognitive Impairment)
Current Clinical Pharmacology Cardiac Morbidity in an HIV-1 Lipodystrophy Patient Cohort Expressing the TNF-α-238 G/A Single Nucleotide Gene Polymorphism
Current HIV Research In-Vivo Gene Delivery by Sonoporation: Recent Progress and Prospects
Current Gene Therapy Isolation, Structural Determination, and Evaluation of the Biological Activity of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol [20(S)-25-OCH3-PPD], a Novel Natural Product from Panax notoginseng
Medicinal Chemistry The Role of Combined Assessment of Defense Against Oxidative Stress and Inflammation in the Evaluation of Peripheral Arterial Disease
Current Molecular Medicine Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors
Endocrine, Metabolic & Immune Disorders - Drug Targets